Home DailyMed ff91007e-190c-45e6-83fd-144d9c19febe National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2013-02-13
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 03:29:56 Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A202910-001 IRBESARTAN IRBESARTAN 75MG TABLET / ORAL AB 2012-09-27 A202910-002 IRBESARTAN IRBESARTAN 150MG TABLET / ORAL AB 2012-09-27 A202910-003 IRBESARTAN IRBESARTAN 300MG TABLET / ORAL AB 2012-09-27
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 129 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A202910-001 IRBESARTAN 75MG TABLET / ORAL AB 2012-09-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202910-002 IRBESARTAN 150MG TABLET / ORAL AB 2012-09-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 A202910-003 IRBESARTAN 300MG TABLET / ORAL AB 2012-09-27 84e616aacf4f…2026-08-18 06:07:40 2026-07 A202910-001 IRBESARTAN 75MG TABLET / ORAL AB 2012-09-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202910-002 IRBESARTAN 150MG TABLET / ORAL AB 2012-09-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A202910-003 IRBESARTAN 300MG TABLET / ORAL AB 2012-09-27 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A202910-001 IRBESARTAN 75MG TABLET / ORAL AB 2012-09-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202910-002 IRBESARTAN 150MG TABLET / ORAL AB 2012-09-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A202910-003 IRBESARTAN 300MG TABLET / ORAL AB 2012-09-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202910-001 IRBESARTAN 75MG TABLET / ORAL AB 2012-09-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202910-002 IRBESARTAN 150MG TABLET / ORAL AB 2012-09-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A202910-003 IRBESARTAN 300MG TABLET / ORAL AB 2012-09-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A202910-001 IRBESARTAN 75MG TABLET / ORAL AB 2012-09-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202910-002 IRBESARTAN 150MG TABLET / ORAL AB 2012-09-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A202910-003 IRBESARTAN 300MG TABLET / ORAL AB 2012-09-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202910-001 IRBESARTAN 75MG TABLET / ORAL AB 2012-09-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202910-002 IRBESARTAN 150MG TABLET / ORAL AB 2012-09-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A202910-003 IRBESARTAN 300MG TABLET / ORAL AB 2012-09-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202910-001 IRBESARTAN 75MG TABLET / ORAL AB 2012-09-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202910-002 IRBESARTAN 150MG TABLET / ORAL AB 2012-09-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A202910-003 IRBESARTAN 300MG TABLET / ORAL AB 2012-09-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A202910-001 IRBESARTAN 75MG TABLET / ORAL AB 2012-09-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A202910-002 IRBESARTAN 150MG TABLET / ORAL AB 2012-09-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A202910-003 IRBESARTAN 300MG TABLET / ORAL AB 2012-09-27 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A202910-001 IRBESARTAN 75MG TABLET / ORAL AB 2012-09-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A202910-002 IRBESARTAN 150MG TABLET / ORAL AB 2012-09-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A202910-003 IRBESARTAN 300MG TABLET / ORAL AB 2012-09-27 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A202910-001 IRBESARTAN 75MG TABLET / ORAL AB 2012-09-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A202910-002 IRBESARTAN 150MG TABLET / ORAL AB 2012-09-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A202910-003 IRBESARTAN 300MG TABLET / ORAL AB 2012-09-27 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A202910-001 IRBESARTAN 75MG TABLET / ORAL AB 2012-09-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A202910-002 IRBESARTAN 150MG TABLET / ORAL AB 2012-09-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A202910-003 IRBESARTAN 300MG TABLET / ORAL AB 2012-09-27 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A202910-001 IRBESARTAN 75MG TABLET / ORAL AB 2012-09-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A202910-002 IRBESARTAN 150MG TABLET / ORAL AB 2012-09-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A202910-003 IRBESARTAN 300MG TABLET / ORAL AB 2012-09-27 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A202910-001 IRBESARTAN 75MG TABLET / ORAL AB 2012-09-27 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A202910-002 IRBESARTAN 150MG TABLET / ORAL AB 2012-09-27 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A202910-003 IRBESARTAN 300MG TABLET / ORAL AB 2012-09-27 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A202910-001 IRBESARTAN 75MG TABLET / ORAL AB 2012-09-27 301d65b070ca…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 129 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.